Picture of Apiam Animal Health logo

AHX — Apiam Animal Health News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall Cap

Australia's Apiam rises as distribution partner gets label approval in U.S.

** Shares of veterinary services provider Apiam Animal
Health  AHX.AX  rise as much as 5.6% to A$0.950, on track for
their best day since Sept 2
    ** Co says distribution partner Aurora Pharmaceutical has
received label approval from  U.S. Environmental Protection
Agency  urn:newsml:reuters.com:*:nASX4WXpnb
    ** Says approval is for Aurora to launch Zoono Microbe
Shield technology as Xtend 21 Antimicrobial Surface Protectant
in the U.S. market 
    ** Apiam had entered into a distribution agreement with
Zoono Animal Health for the latter's surface protection tech in
March 2020 
    ** AHX stock set to snap three consecutive sessions of
losses
    ** As of last close, stock up 39.5% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))

Recent news on Apiam Animal Health

See all news